Halliburton Co has a consensus price target of $43.05 based on the ratings of 26 analysts. The high is $52 issued by UBS on August 17, 2023. The low is $18.2 issued by HSBC on August 5, 2021. The 3 most-recent analyst ratings were released by Barclays, Morgan Stanley, and B of A Securities on July 23, 2024, July 22, 2024, and July 22, 2024, respectively. With an average price target of $44.33 between Barclays, Morgan Stanley, and B of A Securities, there's an implied 33.88% upside for Halliburton Co from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/23/2024 | Buy Now | 44.95% | Barclays | David Anderson | $54 → $48 | Maintains | Overweight | Get Alert |
07/22/2024 | Buy Now | 35.89% | Morgan Stanley | Connor Lynagh | $47 → $45 | Maintains | Overweight | Get Alert |
07/22/2024 | Buy Now | 20.79% | B of A Securities | Chase Mulvehill | $41 → $40 | Maintains | Buy | Get Alert |
07/22/2024 | Buy Now | 44.95% | Evercore ISI Group | James West | $52 → $48 | Maintains | Outperform | Get Alert |
07/22/2024 | Buy Now | 35.89% | TD Cowen | Marc Bianchi | $47 → $45 | Maintains | Buy | Get Alert |
07/22/2024 | Buy Now | 26.83% | Benchmark | Kurt Hallead | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
07/22/2024 | Buy Now | 20.79% | JP Morgan | Arun Jayaram | $45 → $40 | Maintains | Overweight | Get Alert |
07/22/2024 | Buy Now | 32.87% | RBC Capital | Keith Mackey | $45 → $44 | Maintains | Outperform | Get Alert |
07/22/2024 | Buy Now | 20.79% | Piper Sandler | Luke Lemoine | $46 → $40 | Maintains | Overweight | Get Alert |
07/22/2024 | Buy Now | 38.91% | Susquehanna | Charles Minervino | $49 → $46 | Maintains | Positive | Get Alert |
07/16/2024 | Buy Now | 38.91% | Stifel | Stephen Gengaro | $47 → $46 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | 23.81% | B of A Securities | Chase Mulvehill | $45 → $41 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | 38.91% | Piper Sandler | Luke Lemoine | $49 → $46 | Maintains | Overweight | Get Alert |
06/28/2024 | Buy Now | 35.89% | Citigroup | Scott Gruber | $50 → $45 | Maintains | Buy | Get Alert |
05/01/2024 | Buy Now | 50.99% | Jefferies | Lloyd Byrne | $49 → $50 | Maintains | Buy | Get Alert |
04/29/2024 | Buy Now | 47.97% | Wells Fargo | Roger Read | $50 → $49 | Maintains | Overweight | Get Alert |
04/24/2024 | Buy Now | 35.89% | Benchmark | Kurt Hallead | → $45 | Reiterates | Buy → Buy | Get Alert |
04/24/2024 | Buy Now | 50.99% | Citigroup | Scott Gruber | $45 → $50 | Maintains | Buy | Get Alert |
04/24/2024 | Buy Now | 44.95% | TD Cowen | Marc Bianchi | $47 → $48 | Maintains | Buy | Get Alert |
04/08/2024 | Buy Now | 47.97% | Susquehanna | Charles Minervino | $49 → $49 | Maintains | Positive | Get Alert |
02/13/2024 | Buy Now | 47.97% | Susquehanna | Charles Minervino | → $49 | Reiterates | Positive → Positive | Get Alert |
01/24/2024 | Buy Now | 63.07% | Barclays | David Anderson | $55 → $54 | Maintains | Overweight | Get Alert |
01/24/2024 | Buy Now | 47.97% | Susquehanna | Charles Minervino | $51 → $49 | Maintains | Positive | Get Alert |
01/24/2024 | Buy Now | 35.89% | RBC Capital | Keith Mackey | → $45 | Reiterates | Outperform → Outperform | Get Alert |
01/24/2024 | Buy Now | 41.93% | Raymond James | James Rollyson | $49 → $47 | Maintains | Strong Buy | Get Alert |
10/25/2023 | Buy Now | 35.89% | RBC Capital | Keith Mackey | $43 → $45 | Maintains | Outperform | Get Alert |
10/25/2023 | Buy Now | 54.01% | Susquehanna | Charles Minervino | $48 → $51 | Maintains | Positive | Get Alert |
10/18/2023 | Buy Now | 66.09% | Barclays | David Anderson | $49 → $55 | Maintains | Overweight | Get Alert |
10/17/2023 | Buy Now | 47.97% | Raymond James | James Rollyson | $47 → $49 | Maintains | Strong Buy | Get Alert |
10/04/2023 | Buy Now | 44.95% | Susquehanna | Charles Minervino | $44 → $48 | Maintains | Positive | Get Alert |
10/03/2023 | Buy Now | 57.03% | Wells Fargo | Roger Read | $53 → $52 | Maintains | Overweight | Get Alert |
09/11/2023 | Buy Now | 69.11% | Piper Sandler | Luke Lemoine | $46 → $56 | Maintains | Overweight | Get Alert |
08/17/2023 | Buy Now | 57.03% | UBS | Josh Silverstein | $49 → $52 | Maintains | Buy | Get Alert |
08/01/2023 | Buy Now | 35.89% | Morgan Stanley | Connor Lynagh | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
07/21/2023 | Buy Now | 35.89% | Morgan Stanley | Connor Lynagh | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
07/21/2023 | Buy Now | 50.99% | HSBC | Abhishek Kumar | $57 → $50 | Maintains | Buy | Get Alert |
07/20/2023 | Buy Now | 32.87% | Susquehanna | Charles Minervino | $42 → $44 | Maintains | Positive | Get Alert |
07/20/2023 | Buy Now | 35.89% | JP Morgan | Arun Jayaram | $50 → $45 | Maintains | Overweight | Get Alert |
07/20/2023 | Buy Now | 47.97% | Barclays | David Anderson | $58 → $49 | Maintains | Overweight | Get Alert |
07/20/2023 | Buy Now | 41.93% | Raymond James | Praveen Narra | $46 → $47 | Maintains | Strong Buy | Get Alert |
07/17/2023 | Buy Now | 35.89% | Morgan Stanley | Connor Lynagh | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
07/12/2023 | Buy Now | 44.95% | Stifel | Stephen Gengaro | $49 → $48 | Maintains | Buy | Get Alert |
07/03/2023 | Buy Now | 38.91% | UBS | Josh Silverstein | $49 → $46 | Maintains | Buy | Get Alert |
06/28/2023 | Buy Now | 26.83% | Citigroup | Scott Gruber | → $42 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | Buy Now | 38.91% | Raymond James | Praveen Narra | $52 → $46 | Maintains | Strong Buy | Get Alert |
06/13/2023 | Buy Now | 26.83% | Goldman Sachs | Neil Mehta | $45 → $42 | Maintains | Buy | Get Alert |
06/02/2023 | Buy Now | 26.83% | Susquehanna | Charles Minervino | $45 → $42 | Maintains | Positive | Get Alert |
04/26/2023 | Buy Now | 44.95% | TD Cowen | Gabe Daoud | $46 → $48 | Maintains | Outperform | Get Alert |
04/26/2023 | Buy Now | 29.85% | RBC Capital | Keith Mackey | → $43 | Reinstates | → Outperform | Get Alert |
04/19/2023 | Buy Now | 47.97% | UBS | Josh Silverstein | → $49 | Assumes | → Buy | Get Alert |
04/03/2023 | Buy Now | 35.89% | Susquehanna | Charles Minervino | $57 → $45 | Maintains | Positive | Get Alert |
04/03/2023 | Buy Now | 50.99% | Benchmark | Kurt Hallead | → $50 | Reiterates | → Buy | Get Alert |
03/22/2023 | Buy Now | 32.87% | Citigroup | Scott Gruber | $47 → $44 | Maintains | Buy | Get Alert |
03/14/2023 | Buy Now | 72.13% | Susquehanna | Charles Minervino | → $57 | Reiterates | → Positive | Get Alert |
01/30/2023 | Buy Now | 38.91% | Goldman Sachs | Neil Mehta | $40 → $46 | Maintains | Buy | Get Alert |
01/30/2023 | Buy Now | 72.13% | HSBC | Abhishek Kumar | $43.9 → $57 | Maintains | Buy | Get Alert |
01/26/2023 | Buy Now | 75.15% | Barclays | David Anderson | $54 → $58 | Maintains | Overweight | Get Alert |
01/25/2023 | Buy Now | 72.13% | Susquehanna | Charles Minervino | $51 → $57 | Maintains | Positive | Get Alert |
01/25/2023 | Buy Now | 63.07% | Wells Fargo | Roger Read | $52 → $54 | Maintains | Overweight | Get Alert |
01/19/2023 | Buy Now | 50.99% | Benchmark | Kurt Hallead | → $50 | Initiates | → Buy | Get Alert |
01/12/2023 | Buy Now | 54.01% | Wolfe Research | Sam Margolin | → $51 | Upgrade | Underperform → Outperform | Get Alert |
01/04/2023 | Buy Now | 35.89% | Morgan Stanley | Connor Lynagh | $43 → $45 | Maintains | Overweight | Get Alert |
11/18/2022 | Buy Now | 44.95% | Piper Sandler | Luke Lemoine | $43 → $48 | Maintains | Overweight | Get Alert |
11/09/2022 | Buy Now | 60.05% | Morgan Stanley | Connor Lynagh | $50 → $53 | Maintains | Overweight | Get Alert |
10/26/2022 | Buy Now | 29.85% | Morgan Stanley | Connor Lynagh | $42 → $43 | Maintains | Overweight | Get Alert |
10/26/2022 | Buy Now | 63.07% | Barclays | David Anderson | $53 → $54 | Maintains | Overweight | Get Alert |
10/26/2022 | Buy Now | 35.89% | RBC Capital | Keith Mackey | $44 → $45 | Maintains | Outperform | Get Alert |
10/26/2022 | Buy Now | 57.03% | Wells Fargo | Roger Read | → $52 | Upgrade | Equal-Weight → Overweight | Get Alert |
10/19/2022 | Buy Now | 20.79% | Jefferies | Lloyd Byrne | → $40 | Initiates | → Buy | Get Alert |
10/13/2022 | Buy Now | 26.83% | Morgan Stanley | Connor Lynagh | $40 → $42 | Maintains | Overweight | Get Alert |
07/20/2022 | Buy Now | -0.35% | Wells Fargo | Christopher Voie | $42 → $33 | Maintains | Equal-Weight | Get Alert |
07/13/2022 | Buy Now | 20.79% | Morgan Stanley | Connor Lynagh | $45 → $40 | Maintains | Overweight | Get Alert |
07/13/2022 | Buy Now | 5.69% | Goldman Sachs | Neil Mehta | $46 → $35 | Maintains | Buy | Get Alert |
06/08/2022 | Buy Now | 60.05% | Barclays | David Anderson | $50 → $53 | Maintains | Overweight | Get Alert |
04/27/2022 | Buy Now | 50.99% | Barclays | David Anderson | $36 → $50 | Maintains | Overweight | Get Alert |
04/27/2022 | Buy Now | 25.62% | HSBC | Abhishek Kumar | $36.6 → $41.6 | Upgrade | Hold → Buy | Get Alert |
04/20/2022 | Buy Now | 44.95% | Citigroup | Scott Gruber | $44 → $48 | Maintains | Buy | Get Alert |
04/20/2022 | Buy Now | 20.79% | Stephens & Co. | Tommy Moll | $37 → $40 | Downgrade | Overweight → Equal-Weight | Get Alert |
04/20/2022 | Buy Now | 41.93% | B of A Securities | Chase Mulvehill | $45 → $47 | Maintains | Buy | Get Alert |
04/11/2022 | Buy Now | 35.89% | Morgan Stanley | Connor Lynagh | $32 → $45 | Maintains | Overweight | Get Alert |
03/31/2022 | Buy Now | 20.79% | Wells Fargo | Roger Read | $30 → $40 | Maintains | Equal-Weight | Get Alert |
01/25/2022 | Buy Now | -3.37% | Morgan Stanley | Connor Lynagh | $30 → $32 | Maintains | Overweight | Get Alert |
01/13/2022 | Buy Now | -3.37% | JP Morgan | Arun Jayaram | $30 → $32 | Upgrade | Neutral → Overweight | Get Alert |
01/04/2022 | Buy Now | -9.41% | Morgan Stanley | Connor Lynagh | → $30 | Upgrade | Equal-Weight → Overweight | Get Alert |
11/19/2021 | Buy Now | -6.39% | Benchmark | — | — | Initiates | → Buy | Get Alert |
10/20/2021 | Buy Now | -6.39% | RBC Capital | Keith Mackey | — | Maintains | Outperform | Get Alert |
10/20/2021 | Buy Now | -3.37% | Argus Research | Bill Selesky | — | Upgrade | Hold → Buy | Get Alert |
10/20/2021 | Buy Now | 8.71% | Barclays | David Anderson | — | Maintains | Overweight | Get Alert |
10/01/2021 | Buy Now | -33.56% | Wells Fargo | Roger Read | — | Maintains | Equal-Weight | Get Alert |
09/09/2021 | Buy Now | -18.47% | RBC Capital | Keith Mackey | — | Assumes | → Outperform | Get Alert |
08/05/2021 | Buy Now | -45.04% | HSBC | — | — | Upgrade | Reduce → Hold | Get Alert |
The latest price target for Halliburton (NYSE:HAL) was reported by Barclays on July 23, 2024. The analyst firm set a price target for $48.00 expecting HAL to rise to within 12 months (a possible 44.95% upside). 34 analyst firms have reported ratings in the last year.
The latest analyst rating for Halliburton (NYSE:HAL) was provided by Barclays, and Halliburton maintained their overweight rating.
The last upgrade for Halliburton Co happened on January 12, 2023 when Wolfe Research raised their price target to $51. Wolfe Research previously had an underperform for Halliburton Co.
The last downgrade for Halliburton Co happened on April 20, 2022 when Stephens & Co. changed their price target from $37 to $40 for Halliburton Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Halliburton, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Halliburton was filed on July 23, 2024 so you should expect the next rating to be made available sometime around July 23, 2025.
While ratings are subjective and will change, the latest Halliburton (HAL) rating was a maintained with a price target of $54.00 to $48.00. The current price Halliburton (HAL) is trading at is $33.12, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.